DHR vs RTX: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and RTX Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-23.
Danaher Corporation · Healthcare
$221.12
+29.6% upside to fair value
Med Conviction
Grade B
High Quality
VS
RTX Corporation · Industrials
$193.54
+33.0% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
RTX has more upside to fair value
(+33.0%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
RTX |
| Current Price |
$221.12 |
$193.54 |
| Fair Value Estimate |
$286.52 |
$257.36 |
| Upside to Fair Value |
+29.6%
|
+33.0%
|
| Market Cap |
$155.4B |
$260.9B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
18.1x
|
| Price / Sales |
6.2x
|
2.8x
|
| Price / FCF |
28.5x
|
21.7x
|
| Revenue Growth YoY |
+5.5%
|
+14.5%
|
| Gross Margin |
58.5%
|
20.3%
|
| Operating Margin |
20.4%
|
11.2%
|
| Return on Equity |
7.7%
|
11.8%
|
| Dividend Yield |
0.65% |
1.46% |
| FCF Yield |
3.51%
|
4.6%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
Danaher is a diversified life-sciences and diagnostics platform spanning three segments: Life Sciences (mass spectrometers, flow cytometry, genomics, bioprocess technologies), Diagnostics (chemistry, immunoassay, microbiology, hematology, molecular and pathology systems), and Environmental & Applied Solutions (water quality and product-identification instrumentation). The business quality is high…
RTX Corporation is a $260.85 billion aerospace and defense conglomerate operating three segments — Collins Aerospace, Pratt & Whitney, and Raytheon — serving commercial aviation, military, and government customers worldwide with 180,000 employees. The business quality is high: it holds intangible-asset and switching-cost advantages rooted in long-cycle engine programs, proprietary defense electro…
Accumulation Zones
| Metric |
DHR |
RTX |
| Zone Low |
$214.89 |
$193.02 |
| Zone High |
$243.54 |
$218.76 |
| In Buy Zone? |
Yes
|
Yes
|